1. Phase II Study of Dasatinib (BMS‐354825) in Patients With Metastatic Adenocarcinoma of the Pancreas. (26th September 2013) Authors: Chee, Cheng Ean; Krishnamurthi, Smitha; Nock, Charles J.; Meropol, Neal J.; Gibbons, Joseph; Fu, PingFu; Bokar, Joseph; Teston, Lois; O'Brien, Timothy; Gudena, Vinay; Reese, Amy; Bergman, Mark; Saltzman, Joel; Wright, John J.; Dowlati, Afshin; Brell, Joanna Journal: Oncologist Issue: Volume 18:Number 10(2013) Page Start: 1091 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗